Aduhelm Ancillary Costs to Push Medicare Spending Even Higher
A new cost analysis taking into account spending on ancillary health services suggests that prior cost analyses underestimated the anticipated costs of aducanumab.
Medscape Medical News
source https://www.medscape.com/viewarticle/966710?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/966710?src=rss
Comments
Post a Comment